FR2198739A2 - Medicaments contg L-citrulline DL malate - for treating of asthenias and hepatic insufficiency - Google Patents
Medicaments contg L-citrulline DL malate - for treating of asthenias and hepatic insufficiencyInfo
- Publication number
- FR2198739A2 FR2198739A2 FR7232569A FR7232569A FR2198739A2 FR 2198739 A2 FR2198739 A2 FR 2198739A2 FR 7232569 A FR7232569 A FR 7232569A FR 7232569 A FR7232569 A FR 7232569A FR 2198739 A2 FR2198739 A2 FR 2198739A2
- Authority
- FR
- France
- Prior art keywords
- citrulline
- malate
- asthenias
- treating
- hepatic insufficiency
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
L-Citrulline-DL-malate is prepd from L-citrulline (I) and DL-malic acid (II) in aq soln. It may be admin orally at a daily dose of 0.5-3g, and it is formulated as a drink, effervescent tablets, or granules. In an example 8.7g (I) and 6.2g (II) were dissolved separately in water at 50 degrees C. The solns were combined and the water evapd by lyophilisation to give 15g of the salt.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7232569A FR2198739A2 (en) | 1972-09-14 | 1972-09-14 | Medicaments contg L-citrulline DL malate - for treating of asthenias and hepatic insufficiency |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7232569A FR2198739A2 (en) | 1972-09-14 | 1972-09-14 | Medicaments contg L-citrulline DL malate - for treating of asthenias and hepatic insufficiency |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2198739A2 true FR2198739A2 (en) | 1974-04-05 |
FR2198739B2 FR2198739B2 (en) | 1975-11-28 |
Family
ID=9104271
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7232569A Granted FR2198739A2 (en) | 1972-09-14 | 1972-09-14 | Medicaments contg L-citrulline DL malate - for treating of asthenias and hepatic insufficiency |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2198739A2 (en) |
-
1972
- 1972-09-14 FR FR7232569A patent/FR2198739A2/en active Granted
Also Published As
Publication number | Publication date |
---|---|
FR2198739B2 (en) | 1975-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES370058A1 (en) | Antibiotic compositions | |
FR2198739A2 (en) | Medicaments contg L-citrulline DL malate - for treating of asthenias and hepatic insufficiency | |
ES377523A1 (en) | Compound of germanic acid and cysteine | |
GB1011719A (en) | Basic bismuth salt and preparation thereof | |
JPS54151134A (en) | Antitumorigenic agent | |
JPS54105221A (en) | Preparation of stable concentrated dopa injection | |
GB931921A (en) | Therapeutic compositions intended for the treatment of any hepatic malfunctionings | |
GB1286350A (en) | Flufenamate salts of vitamin b6 | |
JPS5328116A (en) | Preparation of glycine | |
GB1176157A (en) | Orotic Acid Salt | |
FR2081583A1 (en) | Threonine proto-glutamate - as hepatoprotective agent | |
FR2047878A1 (en) | Treatment of pheasants using arginine, - ascorbic acid and mineral salts | |
GB1345358A (en) | Antiinflammatory preparations | |
FR2129914A2 (en) | Sulphonic acid salts of aliphatic diamines - with antiviral activity | |
GB1386927A (en) | Preparations for combatting swine dysentery | |
FR2081580A1 (en) | Pharmacol-active 2,4,6-trimethoxybenzoates | |
JPS5271500A (en) | Purification of colesterol | |
GB1253957A (en) | Purification of laurolactam | |
JPS52232A (en) | Process for purification of hydroquinone | |
FR2068438A1 (en) | Glutamine-buffered aspirin/ascorbic acid compositions | |
ES470802A1 (en) | A pharmaceutical composition with an anti-infectious, anti-inflammatory and anti-asthenic effect. | |
JPS5282711A (en) | Extraction of cryogenine | |
FR2092649A1 (en) | Oral antirheumatic compsn - of aceylsalicylic acid magnesium thiomalate, thiamine and ascorbic acid | |
JPS5278818A (en) | Isolation of succinic acid from composition containing glutaric acid, succinic acid and adipic acid | |
GB1099867A (en) | (phenylglycyl)-aminoacetonitriles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CL | Concession to grant licenses |